| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| Other Sizes |
|
| ln Vitro |
γ-DGG (γ-DGG) is an AMPA receptor competitive blocker that blocks less glutamate at greater concentrations. Micro-EPSC (mEPSC) amplitude was decreased by 26±2% (n=5) at 200–400 μM due to the presence of γ-DGG in the bath. Additionally, the mEPSC amplitude distribution and cumulative probability curve were shifted to the left [1]. The strongest antagonist of excitatory postsynaptic potentials (EPSPS) is γ-DGG. Its effects are reversible and unrelated to alterations in the granule cells' passive membrane characteristics or in the EPSPs' apparent reversal potential. γ-DGG's postsynaptic site of action was confirmed when quantitative analysis revealed that the decline in EPSP followed a decline in quantal size rather than quantal content [2].
|
|---|---|
| References |
|
| Additional Infomation |
D-gamma-Glu-Gly is a dipeptide formed from D-gamma-glutamyl and glycine residues.
|
| Molecular Formula |
C7H12N2O5
|
|---|---|
| Molecular Weight |
204.182
|
| Exact Mass |
204.075
|
| CAS # |
6729-55-1
|
| PubChem CID |
6604701
|
| Appearance |
White to off-white solid powder
|
| Boiling Point |
586.6ºC at 760 mmHg
|
| Flash Point |
308.6ºC
|
| LogP |
-4.3
|
| Hydrogen Bond Donor Count |
4
|
| Hydrogen Bond Acceptor Count |
6
|
| Rotatable Bond Count |
6
|
| Heavy Atom Count |
14
|
| Complexity |
240
|
| Defined Atom Stereocenter Count |
1
|
| SMILES |
C(CC(=O)NCC(=O)O)[C@H](C(=O)O)N
|
| InChi Key |
ACIJGUBIMXQCMF-SCSAIBSYSA-N
|
| InChi Code |
InChI=1S/C7H12N2O5/c8-4(7(13)14)1-2-5(10)9-3-6(11)12/h4H,1-3,8H2,(H,9,10)(H,11,12)(H,13,14)/t4-/m1/s1
|
| Chemical Name |
(2R)-2-amino-5-(carboxymethylamino)-5-oxopentanoic acid
|
| Synonyms |
gamma-DGG gamma DGG gammaDGG
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ≥ 150 mg/mL (~734.65 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 25 mg/mL (122.44 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication (<60°C).
(Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.8976 mL | 24.4882 mL | 48.9764 mL | |
| 5 mM | 0.9795 mL | 4.8976 mL | 9.7953 mL | |
| 10 mM | 0.4898 mL | 2.4488 mL | 4.8976 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
